Anionic linear globular dendrimer-G2-ciprofloxacin nano-conjugate: Novel agent against wilson disease cell model

Letters in Drug Design and Discovery

Volumn 11, Issue 7, 2014, Pages 908-916

  Karimi, Narges ^a   Aghasadeghi, Mohammad Reza ^b   Yaghmaei, Parichehr ^a   Moghaddam, Hadi Fathi ^c   Nassiri Koopaei, Nasser ^d   Moloudian, Hamid ^e   Najafi, Saleh ^d   Shandiz, Seyed Ataaollah ^a   Ardestani, Mehdi Shafiee ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Copper; Dendrimer ciprofloxacin nano particle; Fluoroquinolone; Metal ions; Wilson disease

Indexed keywords

ANION; CIPROFLOXACIN; COPPER; DENDRIMER; PENICILLAMINE;

ARTICLE; CELL LEVEL; CONCENTRATION (PARAMETERS); DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; WILSON DISEASE;

EID: 84903722547     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/1570180811666140322001829     Document Type: Article

References (28)

1. Brewer, G.J.; Askari, F.K. Wilson's disease: clinical management and therapy. J. Hepatol., 2005, 42 Suppl(1), S13-21.
2. Roberts, Ea.; Schilsky, M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008, 47(6), 2089-111.
3. Aggarwal, A.; Aggarwal, N.; Nagral, A.; Jankharia, G.; Bhatt, M. A novel Global Assessment Scale for Wilson's Disease (GAS for WD). Movement disorders. J. Move. Disorder Soc., 2009, 24(4), 509-18.
4. Olivarez, L.; Caggana, M.; Pass, Ka.; Ferguson, P.; Brewer, G.J. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann. Hum. Genet., 2001, 65(5), 459-63.
5. Das, S.K.; Ray, K. Wilson's disease: an update. Nature Clin Practice Neurol. 2006, 2(9), 482-93. (Pubitemid 44275724)
6. Hill, G.M.; Brewer, G.J.; Prasad, A.S.; Hydrick, C.R.; Hartmann, D.E. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens. Hepatology, 1987, 7(3), 522-8.
7. Elmi, M.; Rahimi-moghaddam, P.; Abdi, K.; Shafiee-ardestani, M.; Mahmoudian, M. Ciprofloxacin: a novel therapeutic agent for iron overload? Turk J. Haematol., 2009, 26, 114-7.
8. Tom, R.T.; Suryanarayanan, V.; Reddy, P.G.; Baskaran, S.; Pradeep, T. Ciprofloxacin-protected gold nanoparticles. Langmuir: ACS J Surf Coll. 2004, 20(5), 1909-14.
9. MALA, R.; ARUNACHALAM, P.; SIVASANKARI, M. Synergistic bactericidal activity of silver nanoparticles and ciprofloxacin against phytopathogens. J. Cell Tissue Res. 2012, 12(2), 3249-54.
10. López-Gresa, M.P.; Ortiz, R.; Perelló, L.; Latorre, J.; Liu-González, M.; García-Granda, S.; Pérez-Priede, M.; Cantón, E. Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies. J. Inorg. Biochem., 2002, 92(1), 65-74.
11. Turel, I.; Golobic, A.; Klavzar, A.; Pihlar, B.; Buglyó, P.; Tolis, E.; Rehder, D.; Sepcić, K. Interactions of oxovanadium(IV) and the quinolone family member-ciprofloxacin. J. Inorg. Biochem., 2003, 95(2-3), 199-207.
12. Sadeek, Sa.; El-Shwiniy, W.H. Metal complexes of the fourth generation quinolone antimicrobial drug gatifloxacin: Synthesis, structure and biological evaluation. J. Mol. Struct., 2010, 977(1-3), 243-53.
13. Turel, I. The interactions of metal ions with quinolone antibacterial agents. Coord. Chem. Rev., 2002, 232(1-2), 27-47.
14. Gupta, U.; Agashe, H.B.; Asthana, A.; Jain, N.K. A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers. Nanomedicine : nanotechnology, biology, and medicine. 2006, 2(2), 66-73. (Pubitemid 43956608)
15. Zhou, L.; Russell, D.H.; Zhao, M.; Crooks, R.M. Characterization of Poly (amidoamine) Dendrimers and Their Complexes with Cu 2 + by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry. Macromolecules, 2001, 34(11), 3567-73. (Pubitemid 34216892)
16. Shao, N.; Su, Y.; Hu, J.; Zhang, J.; Zhang, H.; Cheng, Y. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Int. J. Nanomedicine., 2011, 6, 3361-72.
17. Freitas, R.A. Current Status of Nanomedicine and Medical Nanorobotics. J. Comput. Theor. Nanosci., 2005, 2, 1-25.
18. Aulenta, F.; Hayes, W.; Rannard, S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur. Polym. J., 2003, 39(9), 1741-71.
19. Medina, S.H.; El-Sayed, M.E.H. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem. Rev., 2009, 109(7), 3141-57.
20. Sampathkumar, S-g.; Yarema, K.J. Dendrimers in Cancer Treatment and Diagnosis 2007. 43 p.
21. Karthikeyan, R.; Karempudi, B.; Rasheed, S.; Vijayaraj, P. Dendritic architechture for the delivery of antibacterial agent against resistant producing strains. Cent. Eur. J. Exp. Biol. 2012, 1(1), 45-8.
22. Mao, Z.; Ma, L.; Gao, C.; Shen, J. Preformed microcapsules for loading and sustained release of ciprofloxacin hydrochloride. Journal of controlled release. J. Cont. Rel. Soc., 2005, 104(1),193-202. (Pubitemid 40615246)
23. Zhang, L.; Gu, F.X.; Chan, J.M.; Wang, A.Z.; Langer, R.S.; Farokhzad, O.C. Nanoparticles in Medicine: Therapeutic Applications and Developments. Clin. Pharmacol. Ther., 2008, 83(5), 761-9.
24. Gajbhiye, V.; Vijayaraj Kumar, P.; Kumar Tekade, R.; Jain, N. Pharmaceutical and Biomedical Potential of PEGylated Dendrimers. Curr. Pharm. Des., 2007, 13(4), 415-29.
25. Carta, M.G.; Mura, G.; Sorbello, O.; Farina, G.; Demelia, L. Quality of Life and Psychiatric Symptoms in Wilson ' s Disease : the Relevance of Bipolar Disorders. Clin. Prac. Epidemiol. Mental Health., 2012, 8.
26. Haririan, I.; Alavidjeh, M.S.; Khorramizadeh, M.R.; Ardestani, M.S.; Ghane, Z.Z.; Namazi, H. Anionic linear-globular dendrimercis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines. Int. J. Nanomedicine., 2010, 5, 63-75.
27. Mirzaei, M.; Mohagheghi, M. Novel Nanosized Gd3+-ALGD-G2-C595: In vivo Dual Selective MUC-1 Positive Tumor Molecular MR Imaging and Therapeutic Agent. J. Nanomed. Nanotechnol., 2012, 03(07).
28. Zakeri, S.; Afzal, E.; Yaghmaei, P.; Mirzaei, M.; Mehravi, B.; Aghasadeghi, R.; Amanlou, M.; Ebrahimi, S.; Namazi, H.; Alavidjeh, M.; Siadat, S.; Delbaz, S.; Sadat, S.; Hekmat, S.; Ardestani. Ml. Nano-scaled Diethylene Triamine Pent Acetic Acid (N-DTPA) : Novel Anti-Wilson ' s Disease Cell Model. Am. J. Biomed. Sci., 2012, 4(3), 204-19.